Analysis of the Clinicopathological Characteristics of Stage I–III Colorectal Cancer Patients Deficient in Mismatch Repair Proteins

References

• Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Gastroenterol Rev. 2019;14(2):89–103. doi:10.5114/pg.2018.81072
   Google Scholar
• Fatima S, Hu X, Huang C, et al. High-fat diet feeding and palmitic acid increase CRC growth in beta2AR-dependent manner. Cell Death Dis. 2019;10(10):711. doi:10.1038/s41419-019-1958-6
   PubMed Web of Science ®Google Scholar
• Penner-Goeke S, Lichtensztejn Z, Neufeld M, et al. The temporal dynamics of chromosome instability in ovarian cancer cell lines and primary patient samples. PLoS Genet. 2017;13(4):e1006707. doi:10.1371/journal.pgen.1006707
   PubMed Web of Science ®Google Scholar
• Vilar E, Gruber SB. Microsatellite instability in colorectal cancer-the stable evidence. Nat Rev Clin Oncol. 2010;7(3):153–162. doi:10.1038/nrclinonc.2009.237
   PubMed Web of Science ®Google Scholar
• Kolodner RD, Marsischky GT. Eukaryotic DNA mismatch repair. Curr Opin Genet Dev. 1999;9(1):89–96. doi:10.1016/S0959-437X(99)80013-6
   PubMed Web of Science ®Google Scholar
• Bedeir A, Krasinskas AM. Molecular diagnostics of colorectal cancer. Arch Pathol Lab Med. 2011;135(5):578–587. doi:10.5858/2010-0613-RAIR.1
   PubMed Web of Science ®Google Scholar
• Hissong E, Crowe E, Yantiss R, et al. Assessing colorectal cancer mismatch repair status in the modern era: a survey of current practices and re-evaluation of the role of microsatellite instability testing. Mod Pathol. 2018;31(11):1756–1766. doi:10.1038/s41379-018-0094-7
   PubMed Web of Science ®Google Scholar
• Graham DM, Appelman HD. Crohn’s-like lymphoid reaction and colorectal carcinoma: a potential histologic prognosticator. Mod Pathol. 1990;3(3):332–335.
   PubMed Web of Science ®Google Scholar
• Michailidi C, Papavassiliou AG, Troungos C. DNA repair mechanisms in colorectal carcinogenesis. Curr Mol Med. 2012;12(3):237–246. doi:10.2174/156652412799218859
   PubMed Web of Science ®Google Scholar
• Genschel J, Littman SJ, Drummond JT, et al. Isolation of MutSbeta from human cells and comparison of the mismatch repair specificities of MutSbeta and MutSalpha. J Biol Chem. 1998;273(31):19895–19901. doi:10.1074/jbc.273.31.19895
   PubMed Web of Science ®Google Scholar
• Hombauer H, Campbell C, Smith C, et al. Visualization of eukaryotic DNA mismatch repair reveals distinct recognition and repair intermediates. Cell. 2011;147(5):1040–1053. doi:10.1016/j.cell.2011.10.025
   PubMed Web of Science ®Google Scholar
• Pluciennik A, Dzantiev L, Iyer R, et al. PCNA function in the activation and strand direction of MutLα endonuclease in mismatch repair. Proc Natl Acad Sci U S A. 2010;107(37):16066–16071. doi:10.1073/pnas.1010662107
   PubMed Web of Science ®Google Scholar
• Goellner EM, Putnam CD, Kolodner RD. Exonuclease 1-dependent and independent mismatch repair. DNA Repair (Amst). 2015;32:24–32. doi:10.1016/j.dnarep.2015.04.010
   PubMed Web of Science ®Google Scholar
• Longley M, Pierce A, Modrich P. DNA polymerase delta is required for human mismatch repair in vitro. J Biol Chem. 1997;272(16):10917–10921. doi:10.1074/jbc.272.16.10917
   PubMed Web of Science ®Google Scholar
• Gupta S, Provenzale D, Llor X, et al. NCCN guidelines insights: genetic/Familial high-risk assessment: colorectal, version 2.2019. J Natl Compr Canc Netw. 2019;17(9):1032–1041. doi:10.6004/jnccn.2019.0044
   PubMed Web of Science ®Google Scholar
• Li K, Luo H, Huang L, et al. Microsatellite instability: a review of what the oncologist should know. Cancer Cell Int. 2020;20(1):16. doi:10.1186/s12935-019-1091-8
   PubMed Web of Science ®Google Scholar
• McGivern A, Wynter CV, Whitehall VL, et al. Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer. Fam Cancer. 2004;3(2):101–107. doi:10.1023/B:FAME.0000039861.30651.c8
   PubMedGoogle Scholar
• Anwar M, Murad F, Dawson E, et al. Immunohistochemistry as a reliable method for detection of BRAF-V600E mutation in melanoma: a systematic review and meta-analysis of current published literature. J Surg Res. 2016;203(2):407–415. doi:10.1016/j.jss.2016.04.029
   PubMed Web of Science ®Google Scholar
• Kim Y, Min B, Kim S, et al. Difference between proximal and distal microsatellite-unstable sporadic colorectal cancers: analysis of clinicopathological and molecular features and prognoses. Ann Surg Oncol. 2010;17(5):1435–1441. doi:10.1245/s10434-009-0888-4
   PubMed Web of Science ®Google Scholar
• Batur S, Vuralli Bakkaloglu D, Kepil N, et al. Microsatellite instability and B-type Raf proto-oncogene mutation in colorectal cancer: clinicopathological characteristics and effects on survival. Bosn J Basic Med Sci. 2016;16(4):254–260. doi:10.17305/bjbms.2016.1238
   PubMed Web of Science ®Google Scholar
• Li W, Li H, Liu R, et al. Comprehensive analysis of the relationship between RAS and RAF mutations and MSI status of colorectal cancer in Northeastern China. Cell Physiol Biochem. 2018;50(4):1496–1509. doi:10.1159/000494649
   PubMedGoogle Scholar
• Kang S, Na Y, Joung S, et al. The significance of microsatellite instability in colorectal cancer after controlling for clinicopathological factors. Medicine (Baltimore). 2018;97(9):e0019. doi:10.1097/MD.0000000000010019
   PubMed Web of Science ®Google Scholar
• Ciardiello D, Vitiello PP, Cardone C, et al. Immunotherapy of colorectal cancer: challenges for therapeutic efficacy. Cancer Treat Rev. 2019;76:22–32. doi:10.1016/j.ctrv.2019.04.003
   PubMed Web of Science ®Google Scholar
• Ismael N, El Sheikh S, Talaat S, et al. Mismatch repair proteins and microsatellite instability in colorectal carcinoma (MLH1, MSH2, MSH6 and PMS2): histopathological and immunohistochemical study. Open Access Maced J Med Sci. 2017;5(1):9–13. doi:10.3889/oamjms.2017.003
   PubMedGoogle Scholar
• Kaur G, Masoud A, Raihan N, et al. Mismatch repair genes expression defects & association with clinicopathological characteristics in colorectal carcinoma. Indian J Med Res. 2011;134:186–192.
   PubMed Web of Science ®Google Scholar
• Gandhi J, Goswami M, Sharma A, et al. Clinical impact of mismatch repair protein testing on outcome of early staged colorectal carcinomas. J Gastrointest Cancer. 2018;49(4):406–414. doi:10.1007/s12029-017-9954-5
   PubMed Web of Science ®Google Scholar
• Kim C, Kim J, Park Y, et al. Prognostic implications of extranodal extension in relation to colorectal cancer location. Cancer Res Treat. 2019;51(3):1135–1143. doi:10.4143/crt.2018.392
   PubMed Web of Science ®Google Scholar
• Fassan M, Vianello L, Sacchi D, et al. Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases. Cancer Cell Int. 2018;18(1):131. doi:10.1186/s12935-018-0634-8
   PubMedGoogle Scholar
• Guidoboni M, Gafà R, Viel A, et al. Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis. Am J Pathol. 2001;159(1):297–304. doi:10.1016/S0002-9440(10)61695-1
   PubMed Web of Science ®Google Scholar
• Yuan L, Chi Y, Chen W, et al. Immunohistochemistry and microsatellite instability analysis in molecular subtyping of colorectal carcinoma based on mismatch repair competency. Int J Clin Exp Med. 2015;8(11):20988–21000.
   PubMed Web of Science ®Google Scholar
• Sinicrope FA, Foster NR, Thibodeau SN, et al. DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy. J Natl Cancer Inst. 2011;103(11):863–875. doi:10.1093/jnci/djr153
   PubMedGoogle Scholar
• Nakagawa-Senda H, Hori M, Matsuda T, et al. Prognostic impact of tumor location in colon cancer: the Monitoring of Cancer Incidence in Japan (MCIJ) project. BMC Cancer. 2019;19(1):431. doi:10.1186/s12885-019-5644-y
   PubMedGoogle Scholar
• Chou C, Lin J, Wang H, et al. Microsatellite instability screening should be done for right-sided colon cancer patients less than 60 years of age. Int J Colorectal Dis. 2010;25(1):47–52. doi:10.1007/s00384-009-0815-y
   PubMed Web of Science ®Google Scholar
• Kim C, Ahn J, Jung M, et al. Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers. Br J Cancer. 2016;115(1):25–33. doi:10.1038/bjc.2016.161
   PubMed Web of Science ®Google Scholar
• Goldstein J, Tran B, Ensor J, et al. Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H). Ann Oncol. 2014;25(5):1032–1038. doi:10.1093/annonc/mdu100
   PubMed Web of Science ®Google Scholar
• Marisa L, Svrcek M, Collura A, et al. The balance between cytotoxic t-cell lymphocytes and immune checkpoint expression in the prognosis of colon tumors. J Natl Cancer Inst. 2018;110(1):110. doi:10.1093/jnci/djx136
   Google Scholar
• Sargent D, Marsoni S, Monges G, et al. Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J Clin Oncol. 2010;28(20):3219–3226. doi:10.1200/JCO.2009.27.1825
   PubMed Web of Science ®Google Scholar
• André T, de Gramont A, Vernerey D, et al. Adjuvant fluorouracil, leucovorin, and oxaliplatin in stage II to III colon cancer: updated 10-year survival and outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study. J Clin Oncol. 2015;33(35):4176–4187. doi:10.1200/JCO.2015.63.4238
   PubMed Web of Science ®Google Scholar
• Overman M, Lonardi S, Wong K, et al. Durable clinical benefit with nivolumab plus Ipilimumab in DNA mismatch repair-deficient/microsatellite instability-high metastatic colorectal cancer. J Clin Oncol. 2018;36(8):773–779. doi:10.1200/JCO.2017.76.9901
   PubMed Web of Science ®Google Scholar